Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.

MLA

Bao, Fang, et al. “Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.” Cancers, vol. 14, no. 16, Aug. 2022, p. 3921. EBSCOhost, https://doi.org/10.3390/cancers14163921.

APA

Bao, F., Liu, J., Chen, H., Miao, L., Xu, Z., & Zhang, G. (2022). Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study. Cancers, 14(16), 3921. https://doi.org/10.3390/cancers14163921

Chicago

Bao, Fang, Jiayue Liu, Haiyang Chen, Lu Miao, Zhaochao Xu, and Guixin Zhang. 2022. “Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.” Cancers 14 (16): 3921. doi:10.3390/cancers14163921.